The importance of rheological parameters in the therapy of microcirculatory disorders

Clinical Hemorheology and Microcirculation

Volumn 42, Issue 1, 2009, Pages 37-46

  Blaha M ^a   Rencova E ^a   Blaha V ^a   Maly R ^a   Blazek M ^a   Studnicka J ^a   Andrys C ^a   Fatorova I ^a   Filip, S ^a   Kaparova M ^a   Prochazkova R ^a   Maly J ^a   Zimova R ^a   Langrova H ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Acute hearing loss; Age related macular degeneration; Diabetic foot; Haemorheology; Microcirculation

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN B; FIBRINOGEN; IMMUNOGLOBULIN M; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOOT DISEASE; HUMAN; LEG DISEASE; MALE; MICROANGIOPATHY; MICROCIRCULATION; PERCEPTION DEAFNESS; PLASMA VISCOSITY; RETINA MACULA AGE RELATED DEGENERATION; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONVALESCENCE; FOOT; FOOT ULCER; HYPERLIPIDEMIA; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PHYSIOLOGY; PLASMAPHERESIS; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA DEGENERATION; SUDDEN DEAFNESS; VASCULARIZATION;

AGED; FEMALE; FOOT; FOOT ULCER; HEARING LOSS, SUDDEN; HUMANS; HYPERLIPIDEMIAS; MACULAR DEGENERATION; MALE; MICROCIRCULATION; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PLASMAPHERESIS; RECOVERY OF FUNCTION;

EID: 67651159258     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: 10.3233/CH-2009-1184     Document Type: Article

References (36)

1. A. Afenyi-Anan, M.E. Brecher and N. Bandarenko, Update on multi-center clinical trials in the United States, Transf. Sci. 36 (2007), 5-12.
2. M. Bláha, Extracorporeal LDL-cholesterol elimination in the treatment of severe familial hypercholesterolemia, Acta Medica (Hradec Králové) 46 (2003), 3-7.
3. M. Bláha, M. Cermanová, V. Bláha, M. Blažek, J. Malý, O. Široký, D. Solichová, S. Flip and V. Řeháček, Safety and tolerability of long lasting LDL-apheresis in familial hyperlipoproteinemia, Ther. Apher. Dial. 11 (2007), 9-15.
4. M. Blažek, M. Bláha, M. Pecka, V. Bláha, V. Mašín and J. Malý, Primary hemostasis in patients treated with LDL-apheresis for severe familial hypercholesterolemia: a prospective pilot trial usual PFA-100 analysis to rationalize therapeutic LDL-apheresis procedure, Hematologica 12 (2007), 371-376.
5. H. Borberg, 25 Jahre LDL-Apherese Erfahrungen und Übersicht, in: Seminar "25 Jahre der LDL-Apherese", Köln, 30 April, 2007.
6. H. Borberg and M. Tauchert, Rheohaemapheresis of ophtalmological diseases and diseases of the microcirculation, Transf. Sci. 34 (2006), 41-49.
7. R. Brunner, R.A. Ridder, R.A. Fischer, P. Walter, K.U. Bartz-Schmidt and K. Heimann, Clinical efficacy of haemorheological treatment using plasma exchange, selective adsorption and membrane differential filtration in maculopathy, retinal vein occlusion and uveal effusion syndrome, Transf. Sci. 17 (1996), 493-498.
8. M.J. Donaldson and J.S. Pulido, Treatment of nonexudative (dry) age-related macular degeneration, Curr. Opin. Ophthalmol. 17 (2006), 267-274.
9. M. Ferrannini, G. Vischini, E. Staffolani, F. Scaccia, N. Miani, M.C. Parravano, M.M. Louis, G. Splendiani and N. Di Daniele, Rheopheresis in vascular diseases, Int. J. Artif. Organs 30 (2007), 923-929.
10. R.P. Finger and A.O. Gostian, Apheresis for idiopathic sudden hearing loss: reviewing the evidence, J. Clin. Apher. 21 (2006), 241-245.
11. J. Harris and P. Sharp, Inner ear antibodies in patients with rapidly progressive sensorineural hearing disorders, Laryngoscope 100 (1990), 516-524.
12. F. Jung, G. Pindur and H. Kiesewetter, Plasma viscosity dependence on proteins and lipoproteins: Results of the Aachen-study, Clin. Hemorheol. 12 (1992), 557-571.
13. R. Klingel, Rheopheresis for dry AMD: controversy requiring mutual respect, J. Clin. Apher. 20 (2005), 169-170.
14. R. Klingel, B. Erdtracht, V. Gauss, A. Piazolo, P. Mausfeld-Lafdhiya and C. Diehm, Rheopheresis in patients with critical limb Ischemia - results of an open label prospective pilot trial, Ther. Apher. Dial. 9 (2005), 473-481.
15. R. Klingel, C. Fassbender, T. Fassbender, B. Erdtracht and J. Berrouschot, Rheopheresis: Rheologic, functional, and structural aspects, Ther. Apher. 4 (2000), 348-357.
16. R. Klingel, C. Fassbender, T. Fassbender and B. Göhlen, Clinical studies to implement rheopheresis for age-related macular degeneration guided by evidence-based-medicine, Transf. Apher. Sci. 29 (2003), 71-84.
17. R. Klingel, Ch. Mumme, T. Fassbender, F. Himmelsbach, U. Altes and J. Lotz, Rheopheresis in patients with ischemic diabetic foot syndrome: results of an open label prospective pilot trial, Ther. Apher. Dial. 7 (2003), 444-455.
18. S. Kobayashi, H. Moriya, K. Maesato, K. Okamoto and T. Ohtake, LDL-apheresis improves arterial occlusive disease with an implication for anti-inflammatory effects, J. Clin. Apher. 20 (2005), 239-243.
19. K. Matschke and F. Jung, Regulation of the myocardial microcirculation, Clin. Hemorheol. Microcirc. 39 (2008), 265-279.
20. K. Matschke, C. Mrowietz, R. Sternitzky, F. Jung and J.-W. Park, Effect of LDL apheresis on oxygen tension in skeletal muscle in patients with cardiac allograft vasculopathy and severe lipid disorder, Clin. Hemorheol. Microcirc. 30 (2004), 263-271.
21. D. Megighian, M. Savastano, L. Salvador, A. Frigo and M. Bolzan, Audiometric and epidemiological analysis of elderly in the Veneto region, Gerontology 46 (2000), 199-204.
22. T.I. Metelitsina, J.E. Grunwald, J.C. DuPont, G.S. Ying, A.J. Brucker and J.L. Dunaief, Foveolar chorioidial circulation and chorioidial neovascularization in age-related macular degeneration, Invest. Ophtalmol. Vis. Sci. 49 (2008), 358-363.
23. K. Michalska-Malecka, L. Slovinska, M. Vrecka and W. Romanin, Correlations in some pathogenic factors and values of hemorheological parameters in age related macular degeneration, Clin. Hemorheol. Microcirc. 38 (2008), 209-216.
24. L. Norgren, W.R. Hyatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, F.G. Fowkes, R.B. Rutherford and TASC II Working Group, Inter-society consensus for the management of peripheral arterial disease, Int. Angiol. 26 (2007), 81-157.
25. OccuLogics Reports Positive Mira-1 Analysis Results, http://www. mdsupport.org/library/rheotri3.html, last accessed October 2, 2006.
26. J.-W. Park, C. Mrowietz, S. Schüler, C. Labarrere and F. Jung, Cutaneous microcirculation in cardiac allograft recipients with severe hypercholesterolemia before, during, and after the first HELP apheresis, Appl. Cardiopulm. Pathophys. 9 (2000), 19-25.
27. H. Propher and W. Ramlow, Sudden hearing loss and HELP apheresis - a single center experience, Inter. J. Artif. Org. 30 (2007), 689.
28. J.S. Pulido and Multicenter Investigation of Rheopheresis for AMD (MIRA-l) Study Group: Multicenter prospective, randomized, double-masked, placebo-controlled study of rhopheresis to treat nonexudative age-related macular degeneration: interim analysis, Trans. Am. Ophthalmol. Soc. 1 (2002), 85-107.
29. J.S. Pulido, J.L. Winters and D. Boyer, Preliminary analysis of the final multicenter investigation of rheopheresis for age related macular degeneration (AMD) trial (MIRA-1) results, Trans. Am. Ophthalmol. Soc. 104 (2006), 1-231.
30. M.-W. Ramping, The great divide: from viscometer to vasculature, Clin. Hemorheol. Microcirc. 39 (2008), 9-20.
31. A. Ramunni, N. Quaranta, M.T. Saliani, R.A. Fallacara, R. Ria and G. Ranili, Does the reduction of adhesion molecules by LDL-apheresis have a role in the treatment of sudden hearing loss?, Ther. Apher. Dial. 10 (2006), 282-286.
32. F. Soudavar, R.A. Widder, R. Brunner, P. Walter, K.U. Bartz-Schmitz and H. Borberg, Changes of retinal haemodynamics after elimination of high molecular weight proteins and lipids in patients with age-related macular degeneration, Invest. Ophthalmol. Vis. Sci. 39 (1998), 386.
33. M. Suckfüll, Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial, Lancet 360 (2002), 1811-1817.
34. H. Ullrich, T. Kleinjung, T. Steffens, P. Jacob, G. Schmitz and J. Strutz, Improved treatment of sudden hearing loss by specific fibrinnogen apheresis, J. Clin. Apher. 19 (2004), 71-78.
35. M. Valbonesi, F. Mora, R. Mora and P. Carlier, Rheopheresis for sudden hearing loss (SHL), Inter. J. Artif. Org. 27 (2004), 806-809.
36. S. Wolf, K. Schulte, O. Arend, M.-W. Glöckner, S. Handt, F. Jung and M. Reim, Correlation between retinal microcirculation, plasma viscosity and visual function in patients with macroglobulinemia, Clin. Hemorheol. 12 (1992), 725-731.